Table 1.

Sample cohort

Additional annotation	Age at time of surgery	Reason for surgery	Gravida	Para	Days since LMPa	No. cells analyzed	Mean reads per cell	Median genes per cell
Patient 1
mid-portion	47	symptomatic fibroids, adenomyosis, endometriosis	1	0	3	1,614	259,280	1,636
Patient 2
mid-portion	35	symptomatic fibroids	0	0	18	3,229	153,799	1,313
Patient 3
ampulla	47	symptomatic fibroids	3	2	17	2,873	203,866	1,032
Patient 4
mid-portion	41	symptomatic fibroids, adenomyosis, endometriosis	2	0	7	2,448	62,427	709
Patient 5
mid-portion (left)	33	symptomatic fibroids	0	0	31b	3,063	81,873	882
mid-portion (right)	33	symptomatic fibroids	0	0	31b	3,129	44,293	784
Patient 6
ampulla	31	uterine didelphys	0	0	13	10,764	36,015	967
infundibulum	31	uterine didelphys	0	0	13	11,572	31,578	936
fimbriae	31	uterine didelphys	0	0	13	8,343	54,001	1,596
Patient 7
mid-portion	46	symptomatic fibroids	3	2	23	4,498	84,674	1,048
fimbriae	46	symptomatic fibroids	3	2	23	7,173	50,127	967
Patient 8
fimbriae	62	symptomatic fibroids, endometrial polyps	2	0	NAc	5,336	92,059	1,124

^aInterval between start of last menstrual period (LMP) and date of surgery

^bPatient-reported regular 35-day cycles

^cNot applicable, patient is post-menopausal